drugset
drugset / Trial / NCT05008588

Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct

NCT05008588 ↗

Phase 1/2 Active not recruiting 15 enrolled PT. Prodia Stem Cell Indonesia
RandomizedFactorialOpen-labelTreatment

Summary

The purpose of this study was to determine the effectiveness of a combination of intranasal conditioned medium (CM) with intraparenchymal umbilical cord mesenchymal stem cells (UC-MSCs) transplantation in acute stroke patients to induce neurogenesis.

Timeline

Start
2022-05-30
Primary completion
2026-03
Completion
2026-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Secretome Other / unclassified 3 ml Intranasal
Subject mesenchymal stem cells Cell therapy 2e+07 cells Other

Indications

ischemic stroke